Diligence memo · auto-generated · as of July 3, 2026
Avertix Medical, Inc.
Avertix Medical, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Avertix Medical, Inc. operates in Healthtech, based in EATONTOWN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Avertix Medical, Inc. has raised $121M in disclosed capital across 11 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $34M on 2023-02-15.
Most recent recorded round closed around 2025-09-10.
Valuation (modeled)modeled
Provath models Avertix Medical, Inc. at approximately $4.7M (range $2.4M–$6.6M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.05× the median modeled value of Series B Healthtech companies in 2025–2027 (55 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 10 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 14.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 96% of Healthtech peers (2138 compared).
Modeled value ranks above 22% of those peers.
Closest niche peers: Sevaro Health Inc, Field Medical, Inc., Berry Street Health, Inc., Puzzle Medical Devices Inc., Cartwheel Care Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.